As many as 28 chapters in this book deal with echocardiography and HFpEF. Assessment of HFpEF using echocardiographic techniques such as three-dimensional echocardiography and more recent advances such as speckle tracking of echocardiography for assessment of left ventricular, left atrial, right ventricular, and right atrial strain are well covered in the book. Echocardiographic ventricular and atrial remodeling reversal with various therapeutic agents including sodium‐glucose cotransporter‐2 (SGLT2) inhibitors, angiotensin receptor–neprilysin inhibitor (ARNI), and bisoprolol is given due prominence. In addition, the use of echocardiography in guiding therapy and evaluating prognosis in HFpEF is well described. An interesting chapter deals with exercise-induced left atrial hypertension in HFpEF. The effect of various therapeutic agents on left atrial stiffness index, left atrial function, and other left ventricular diastolic parameters is also well discussed. The section also focuses on specific disease entities such as hypertrophic cardiomyopathy, amyloidosis, and sarcoidosis that lead to HFpEF. All-in-all, this book provides a comprehensive coverage of recent advances in the use of various echocardiography modalities in the assessment of HFpEF.